Lightrock Netherlands B.V. Makes New Investment in Envista Holdings Co. (NYSE:NVST)

Lightrock Netherlands B.V. acquired a new stake in Envista Holdings Co. (NYSE:NVST - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 267,900 shares of the company's stock, valued at approximately $5,193,000. Envista comprises about 1.8% of Lightrock Netherlands B.V.'s investment portfolio, making the stock its 26th largest holding. Lightrock Netherlands B.V. owned 0.16% of Envista as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Envista in the 3rd quarter valued at approximately $31,000. GAMMA Investing LLC increased its position in shares of Envista by 69.8% in the 3rd quarter. GAMMA Investing LLC now owns 1,766 shares of the company's stock valued at $35,000 after purchasing an additional 726 shares during the last quarter. Huntington National Bank grew its position in shares of Envista by 97.8% in the 3rd quarter. Huntington National Bank now owns 1,919 shares of the company's stock valued at $38,000 after buying an additional 949 shares during the last quarter. Blue Trust Inc. grew its position in shares of Envista by 69.7% in the 3rd quarter. Blue Trust Inc. now owns 1,957 shares of the company's stock valued at $39,000 after buying an additional 804 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC grew its position in shares of Envista by 50.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company's stock valued at $43,000 after buying an additional 728 shares during the last quarter.

Envista Stock Performance

Shares of NVST stock traded up $0.08 during mid-day trading on Friday, hitting $21.59. The stock had a trading volume of 957,228 shares, compared to its average volume of 2,183,121. Envista Holdings Co. has a fifty-two week low of $15.15 and a fifty-two week high of $23.06. The firm has a market cap of $3.71 billion, a PE ratio of -3.33, a PEG ratio of 2.06 and a beta of 1.34. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.04 and a quick ratio of 1.77. The company's 50-day simple moving average is $19.93 and its 200-day simple moving average is $19.29.

Envista (NYSE:NVST - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, topping the consensus estimate of $0.23 by $0.01. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. Sell-side analysts anticipate that Envista Holdings Co. will post 1.06 earnings per share for the current year.

Analyst Upgrades and Downgrades

NVST has been the topic of a number of recent analyst reports. Piper Sandler increased their target price on shares of Envista from $17.00 to $18.00 and gave the company a "neutral" rating in a research report on Monday, February 3rd. Wells Fargo & Company increased their target price on shares of Envista from $20.00 to $21.00 and gave the company an "equal weight" rating in a research report on Thursday, February 6th. Needham & Company LLC reaffirmed a "hold" rating on shares of Envista in a research report on Thursday, February 6th. Stifel Nicolaus increased their target price on shares of Envista from $18.00 to $21.00 and gave the company a "buy" rating in a research report on Wednesday, October 23rd. Finally, Leerink Partners raised shares of Envista from an "underperform" rating to a "market perform" rating and increased their target price for the company from $16.00 to $23.00 in a research report on Thursday, October 31st. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, Envista has a consensus rating of "Hold" and a consensus price target of $20.21.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.